Origami Surgical

Executive Summary

Origami Surgical, based in Cambridge, MA, has developed StitchKit, a novel device that eliminates lost needles during robotic surgery. Traditional robotic procedures require manual needle transfer, which risks needle loss and subsequent complications. StitchKit streamlines this process by enabling direct, closed-loop needle exchange within the robotic instrument, enhancing surgeon autonomy and patient safety. The device addresses a critical unmet need, as retained surgical items remain a persistent challenge in minimally invasive surgery. With a focus on reducing preventable adverse events, Origami Surgical aims to improve operating room efficiency and outcomes. The company is well-positioned in the rapidly growing robotic surgery market, where demand for safer and more efficient tools is high. StitchKit's potential to reduce operative time and mitigate legal risks makes it an attractive solution for hospitals and surgical teams.

Upcoming Catalysts (preview)

• TBDFDA 510(k) clearance for next-generation StitchKit with expanded compatibility70% success
• TBDStrategic partnership with a major robotic surgery platform (e.g., Intuitive Surgical, Medtronic)45% success